Head-To-Head Comparison Of Subcutaneous Abatacept Versus Adalimumab On Background Methotrexate In RA: Blinded Two Year Results From The Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjectswith Background Methotrexate) study

被引：0

作者：

Weinblatt, Michael E. ^{[1
]}

Schiff, Michael H. ^{[2
]}

Valente, Robert ^{[3
]}

van der Heijde, Desiree M. ^{[4
]}

Citera, Gustavo ^{[5
]}

Elegbe, Ayanbola ^{[6
]}

Maldonado, Michael A. ^{[6
]}

Fleischmann, Roy M. ^{[7
]}

机构：

[1] Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Univ Colorado, Denver, CO 80202 USA

[3] Arthrit Ctr Nebraska, Lincoln, NE USA

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina

[6] Bristol Myers Squibb Co, Princeton, NJ USA

[7] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

ARTHRITIS AND RHEUMATISM | 2013年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2326

引用

页码：S991 / S992

页数：2

共 47 条

[1] Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Blinded Two-Year Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Study
Weinblatt, Michael
Schiff, Michael
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Elegbe, Ayanbola
Maldonado, Michael
Fleischmann, Roy
[J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1476 - 1476
[2] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RA: TWO YEAR RESULTS FROM THE AMPLE STUDY
Schiff, M.
Weinblatt, M.
Valente, R.
van der Heijde, D.
Citera, G.
Elegbe, A.
Maldonado, M.
Fleischmann, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 64 - 64
[3] Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Maldonado, Michael
Weinblatt, Michael
Schiff, Michael
Fleischmann, Roy
Valente, Robert
Van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1005 - 1006
[4] Head to Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Weinblatt, Michael E.
Schiff, Michael H.
Fleischmann, Roy
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
Maldonado, Michael A.
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1031 - S1031
[5] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY
Weinblatt, Michael E.
Schiff, Michael H.
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Elegbe, Ayanbola
Maldonado, Michael A.
Fleischmann, Roy
[J]. RHEUMATOLOGY, 2014, 53 : 88 - 88
[6] Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Maldonado, Michael
Fleischmann, Roy
Weinblatt, Michael
Schiff, Michael
Khanna, Dinesh
Furst, Daniel
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1006 - 1006
[7] ABATACEPT SC VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RA: ONE YEAR RESULTS FROM THE AMPLE STUDY
Schiff, M.
Fleischmann, R.
Weinblatt, M.
Valente, R.
van der Heijde, D.
Citera, G.
Zhao, C.
Maldonado, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 60 - 60
[8] EFFECTS OF SUBCUTANEOUS ABATACEPT OR ADALIMUMAB ON REMISSION AND ASSOCIATED CHANGES IN PHYSICAL FUNCTION AND RADIOGRAPHIC OUTCOMES: ONE YEAR RESULTS FROM THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
Fleischmann, R.
Schiff, M.
Weinblatt, M.
Maldonado, M.
Massarotti, E.
Yazici, Y.
[J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 11 - 11
[9] CHANGES IN PATIENT REPORTED OUTCOMES IN RESPONSE TO SUBCUTANEOUS ABATACEPT OR ADALIMUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
Fleischmann, R.
Weinblatt, M.
Schiff, M.
Khanna, D.
Furst, D.
Maldonado, M.
[J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 10 - 11
[10] CLINICAL RESPONSES BY BASELINE RA DISEASE DURATION IN THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA PATIENTS WITH BACKGROUND METHOTREXATE) TRIAL: 2-YEAR RESULTS
Schiff, M.
Weinblatt, M. E.
Valente, R.
van der Heijde, D.
Citera, G.
Maldonado, M. A.
Fay, J.
Fleischmann, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 387 - 388

← 1 2 3 4 5 →